Adapta
Payments companies reported to CMS as associated with Adapta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Adapta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Adapta
These are the largest totals companies reported as associated with Adapta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ethan Munzinger | Searcy, AR | Cardiovascular Disease | $1,055.45 |
| Neil Sawhney | Santa Cruz, CA | Cardiovascular Disease | $676.04 |
| Bhavananda Reddy | Farmington, UT | Interventional Cardiology | $670.85 |
| Janet Otto | Idaho Falls, ID | Clinical Cardiac Electrophysiology | $553.12 |
| Marian Holland | La Jolla, CA | Cardiovascular Disease | $541.46 |
| Faraz Luni | Orem, UT | Clinical Cardiac Electrophysiology | $500.55 |
| Wasiq Zaidi | Peoria, AZ | Interventional Cardiology | $434.14 |
| Vamsee Yaganti | Salt Lake City, UT | Interventional Cardiology | $308.70 |
| Evbu Enakpene | Midland, TX | Cardiovascular Disease | $306.41 |
| Yuri Khodakov | Ogden, UT | Interventional Cardiology | $288.50 |
Prescribed Adapta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.